Al-Kuraishy, H.M.; Al-Gareeb, A.I.; Albogami, S.M.; Jean-Marc, S.; Nadwa, E.H.; Hafiz, A.A.; A. Negm, W.; Kamal, M.; Al-Jouboury, M.; Elekhnawy, E.;
et al. Potential Therapeutic Benefits of Metformin Alone and in Combination with Sitagliptin in the Management of Type 2 Diabetes Patients with COVID-19. Pharmaceuticals 2022, 15, 1361.
https://doi.org/10.3390/ph15111361
AMA Style
Al-Kuraishy HM, Al-Gareeb AI, Albogami SM, Jean-Marc S, Nadwa EH, Hafiz AA, A. Negm W, Kamal M, Al-Jouboury M, Elekhnawy E,
et al. Potential Therapeutic Benefits of Metformin Alone and in Combination with Sitagliptin in the Management of Type 2 Diabetes Patients with COVID-19. Pharmaceuticals. 2022; 15(11):1361.
https://doi.org/10.3390/ph15111361
Chicago/Turabian Style
Al-Kuraishy, Hayder M., Ali I. Al-Gareeb, Sarah M. Albogami, Sabatier Jean-Marc, Eman Hassan Nadwa, Amin A. Hafiz, Walaa A. Negm, Marwa Kamal, Mohammed Al-Jouboury, Engy Elekhnawy,
and et al. 2022. "Potential Therapeutic Benefits of Metformin Alone and in Combination with Sitagliptin in the Management of Type 2 Diabetes Patients with COVID-19" Pharmaceuticals 15, no. 11: 1361.
https://doi.org/10.3390/ph15111361
APA Style
Al-Kuraishy, H. M., Al-Gareeb, A. I., Albogami, S. M., Jean-Marc, S., Nadwa, E. H., Hafiz, A. A., A. Negm, W., Kamal, M., Al-Jouboury, M., Elekhnawy, E., Batiha, G. E.-S., & Waard, M. D.
(2022). Potential Therapeutic Benefits of Metformin Alone and in Combination with Sitagliptin in the Management of Type 2 Diabetes Patients with COVID-19. Pharmaceuticals, 15(11), 1361.
https://doi.org/10.3390/ph15111361
